Navigation Links
Lilly and Amylin Enter Into Supply Agreement for Exenatide Once Weekly
Date:10/21/2008

of first-in-class and best-in-class pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Indiana, Lilly provides answers -- through medicines and information -- for some of the world's most urgent medical needs. Additional information about Lilly is available at http://www.lilly.com.

This press release contains forward-looking statements about Amylin and Lilly. Actual results could differ materially from those discussed or implied in this press release due to a number of risks and uncertainties, including the risk that BYETTA and the revenues generated from BYETTA or exenatide once weekly may be affected by competition; unexpected new data; safety and technical issues; exenatide once weekly may not be submitted in a timely manner or receive regulatory approval; or manufacturing and supply issues including risks that the manufacturing facility mentioned in this press release will not be completed in a timely manner or receive regulatory approval. The potential for BYETTA or, if approved, exenatide once weekly may also be affected by government and commercial reimbursement and pricing decisions, the pace of market acceptance, or scientific, regulatory and other issues and risks inherent in the commercialization of pharmaceutical products. These and additional risks and uncertainties are described more fully in Amylin's and Lilly's most recent SEC filings including their Quarterly Reports on Form 10-Q and Annual Reports on Form 10-K. Amylin and Lilly undertake no duty to update these forward-looking statements.

P-LLY


'/>"/>
SOURCE Amylin Pharmaceuticals, Inc.; Eli Lilly and Company
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Emisphere Technologies, Inc. and Eli Lilly and Company Settle Ongoing Litigation
2. Lilly Declares Fourth-Quarter Dividend
3. Robert Conley, M.D. to Join Lilly; Will assume a neuroscience leadership role as a Distinguished Lilly Scholar
4. Lilly and BioMS Medical Announce Global Licensing and Development Agreement
5. Daiichi Sankyo, Lilly Submit New Drug Application for Investigational Antiplatelet Drug, Prasugrel, with U.S. Food and Drug Administration
6. In response to a New England Journal of Medicine article published yesterday and subsequent media coverage, Eli Lilly and Company issued the following statement:
7. Lilly Announces Termination of AIR Insulin Program
8. HistoRx and Lilly Extend, Expand AQUA(R) Analysis Partnership
9. Pelikan Technologies and Lilly Form Alliance to Promote Diabetes Education
10. Lilly Reports Solid First-Quarter Results
11. Lilly CEO Praises Massachusetts Leadership in Biotech, Urges Policy Prescriptions to Help Ensure States Investment Generates Dividends and Jobs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... May 17, 2013  Cellular Biomedicine Group (OTCQB: ... enrollment of the total projected enrollment required for ... and preliminary efficacy of the medical technology haMPC ... Osteoarthritis (KOA). To date the trial has had ... The Phase I open label clinical research trial ...
(Date:5/17/2013)... Men’s skin is biologically different than women’s ... and has been known to react more aggressively when hormones ... far from puberty, other acne causing factors like P.acnes bacteria ... threatening skin with unsightly acne scars. Adult acne treatment, Probiotic ... on how to reduce and prevent acne scarring. , ...
(Date:5/17/2013)... Brea, CA (PRWEB) May 17, 2013 IAC ... DisperSol Technologies, a start up laboratory needing to set up ... be moving to a larger facility within a year’s time. ... the knowledge that the laboratory is temporary? What is efficient ... 4 Series modular workstations from IAC Industries. The planners at ...
(Date:5/16/2013)... May 16, 2013 Oven Industries, Inc. ... controllers and temperature sensors since 1964. Expertly ... in industrial control system applications. As one ... includes a generic, control loop feedback system, which helps ... used to adjust a systematic process, using a control ...
Breaking Biology Technology:Cellular Biomedicine Group Achieves 50% Enrollment Milestone in Phase I Clinical Trial for Knee Osteoarthritis 2Adult Acne Treatment, Probiotic Action Shares New Insight on Why Men’s Skin Scars from Acne and How to Prevent It 2New Downloadable Success Story: “How To Outfit a Dynamic Lab in Flux” 2New PID Temperature Controllers Announced by Oven Industries Inc. 2
... Oct. 6 Environmental,Tectonics Corporation,s (Amex: ETC ... announced the sale of two (2) BARA-MED(R) XD,Monoplace ... ETC is delighted to work with Saint ... The 597-bed institution,is one of the largest health ...
... 6 Caprion Proteomics Inc. announced,today that it has ... of Allergy and Infectious Diseases (NIAID), a part of ... research in the area,of infectious disease biomarkers., Under ... Caprion,will act as one of two NIAID Clinical Proteomics ...
... AALST , Belgium, AHMEDABAD, India and GOTTINGEN, ... associates,Cardiovascular Center Aalst and J.B. Dahm, MD ... Laboratories joint venture, called imaeon., imaeon ... medical images,analysis for clinical research projects, including ...
Cached Biology Technology:Environmental Tectonics Corporation Announces the Placement of Two Monoplace Hyperbaric Chambers at Saint Barnabas Medical Center in New Jersey 2Environmental Tectonics Corporation Announces the Placement of Two Monoplace Hyperbaric Chambers at Saint Barnabas Medical Center in New Jersey 3Environmental Tectonics Corporation Announces the Placement of Two Monoplace Hyperbaric Chambers at Saint Barnabas Medical Center in New Jersey 4Caprion Awarded US $12.9M Infectious Disease Biomarker Research Contract 2Core Laboratories Joint Venture Agreement Between genae associates, VIBGYOR Scientific Research, Cardiovascular Center Aalst and J.B. Dahm 2
(Date:5/16/2013)... and athletes choose to wear the color red when ... Psychological Science , a journal of the Association ... do with their testosterone levels. , The new study, ... of Sunderland and colleagues, demonstrated that males who chose ... higher testosterone levels than other males who chose blue. ...
(Date:5/16/2013)... are about 23 million years old give unprecedented ... order, one of the most species-rich groups among ... paleontologist Professor Bettina Reichenbacher from the Division of ... and Environmental Sciences at Ludwig-Maximilians-Universitaet (LMU) in Munich ... fish fossils which they assign to the group ...
(Date:5/16/2013)... around the world are meeting next week in ... showcase the latest in research findings about the ... understanding the disorders that affect them., "Canada is ... will showcase the best of neuroscience research done ... President of the Canadian Association for Neuroscience. He ...
Breaking Biology News(10 mins):High-testosterone competitors more likely to choose red 2Paleontology: The eloquence of the otoliths 2Paleontology: The eloquence of the otoliths 37th Annual Canadian Neuroscience Meeting, Toronto, May 20-24, 2013 2
... Netherlands: Transferring just one embryo at a time to ... diagnosis (PGD) and freezing at the blastocyst stage has ... that were as good as those for blastocysts that ... freezing. Their results mean that it will be possible ...
... discovered gene expression differences that could lead to better ... arthritis (JIA). Eventually such findings could enable doctors to ... more severe arthritis, while those likely to have milder ... a greater risk of side effects. The researchers were ...
... Dallas, TX (June 29, 2009) -- A team of experts ... the South African bilateral amputee track athlete, have just published ... Some of their previously confidential findings were presented to ... in May of 2008. Other findings are now being ...
Cached Biology News:Single thawed embryo transfer after PGD does not affect pregnancy rates 2Single thawed embryo transfer after PGD does not affect pregnancy rates 3Gene expression findings a step toward better classification and treatment of juvenile arthritis 2Gene expression findings a step toward better classification and treatment of juvenile arthritis 3Oscar Pistorius: Previously confidential study results released on amputee sprinter 2
1M stock solution (238mg/ml)...
...
Request Info...
... Clone/PAD: ZMD.330. Immunogen: Synthetic peptide ... of rat and mouse protein kinase C ... the rat and mouse PKCzeta protein. ... does not cross-react with PKCiota/lambda. Reactivity: ...
Biology Products: